Any trial data that slips out or comments by the FDA could have a huge impact on ACAD stock. Julian Close became a stockbroker in 1995. In his 20 years of market experience, he has seen all market conditions and written about every …
Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) traded down about 27% Monday to post a new 52-week low of $15.74 after closing Friday at $21.53. The stock’s 52-week high is $41.20. Volume was more 10 times the daily average of around 2 …
A 1-for-20 reverse stock split was implemented on January 26, 2018. Clinical Trials & Near-term Catalysts: The lead drug candidate is M207 for the treatment of migraine. A long-term safety study of M207 is underway. -- The Company …
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) today announced that it intends to offer and sell, subject to market and other conditions, $150,000,000 of shares of its common stock in an underwritten public offering. There can be no …
ticker=ACAD Daré Bioscience, Inc. shares closed up 56.69% on Wednesday with around 29 million shares traded. The stock saw its shares explode after the company announced that it has secured an exclusive license to Juniper …
WAND1mon
According to the investigation the issuance of the additional shares could have a severe dilutive effect on the shares of …
All four are rated Buy at Merrill Lynch. This stock got tagged recently, offering investors a very solid entry point. ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) is a biopharmaceutical company based in San Diego and focused on the …
The 2012 SandHills Stock Show & Rodeo Director Angie Bryant, President Bill Wight and Vice President Kevin Evans presented scholarships to the 2012 Miss Rodeo SandHills Ashley Buffington, Miss Rodeo SandHills Teen Carlie Porter …
SAN DIEGO (AP) — Acadia Pharmaceuticals Inc. (ACAD) on Friday reported a loss of $54.3 million ... Acadia shares have decreased 47 percent since the beginning of the year. The stock has fallen 51 percent in the last 12 months.
SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company …